EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Revolutionizing Healthcare: Gene Editing for Genetic Disorders with CRISPR Technology
Gene editing using CRISPR Clustered Regularly Interspaced Short Palindromic Repeats technology has the potential to revolutionize healthcare particularly in addressing genetic disorders
Advanced Robotics and Autonomous Operations in Pharma Production
Walk the production floor of almost any modern European pharmaceutical site and you will find robots already at work Sixaxis arms denest syringe tubs Gantries load and unload lyophilisers Autonomous mobile units ferry pallets between the warehouse and the dispensary Robotics arrived in pharmaceutical manufacturing more than two decades ago and in the purely mechanical sense the argument was won lo...
Post-Pandemic Trends: Reshaping the Future of European Pharma
The widespread influence of the COVID pandemic has deeply affected industries worldwide and the European pharmaceutical sector is no stranger to this impact This article delves into the lasting repercussions of the pandemic
Accelerated Approval Pathways: Speed Without the Stumbles
When a therapy for a devastating disease sits finished in a laboratory while patients wait the arithmetic of a traditional approval timeline becomes unbearable Europes accelerated approval pathways were built precisely for this moment to compress the distance between a promising molecule and a prescription pad
B2B Pharma Editorial Opportunities: Boosting Brand Visibility in Industry Magazines
The teams which previously counted greatly on banner advertisements email newsletters and sponsorship of various events are beginning to reevaluate the source of true influence Since such channels have a role to play they seldom earn credibility alone In contrast a wellplaced article in a respected industry publication can do something most campaigns struggle to achieveit makes people take you ser...
The Role of Technology in Drug Anti-Counterfeiting Efforts
With the rise of drug counterfeiting posing a serious threat to global public health the role of technology in anticounterfeiting efforts has become increasingly vital As counterfeit drugs continue to infiltrate the market
-
Techno Trends
USF Researchers Identify New P. vivax Vaccine Target
Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax a major malaria parasite found across parts of Asia and Central and South America
-
Projects
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Advanced Robotics and Autonomous Operations in Pharma Production
Lakshmi
European pharmaceutical plants are not short of robots. What they lack is autonomy — machines trusted to decide. This feature examines the shift from supervised automation to conditional autonom...
-
2
Post-Pandemic Trends: Reshaping the Future of European Pharma
Kate Williamson
Examining the aftermath of the COVID-19 pandemic, this article delves into how the European pharmaceutical sector is transforming. Key trends include the integration of digital health, heightened focu...
-
3
Accelerated Approval Pathways: Speed Without the Stumbles
Lakshmi
Europe's expedited routes — conditional marketing authorisation, approval under exceptional circumstances, and the PRIME scheme — let promising therapies reach patients years early by...
-
4
B2B Pharma Editorial Opportunities: Boosting Brand Visibility in Industry Magazines
Kate Williamson
B2B pharma editorial opportunities provide a reputable means of creating brand awareness via industry magazines. Through sponsored content and guest articles, companies are able to exchange knowledge,...
-
5
The Role of Technology in Drug Anti-Counterfeiting Efforts
Kate Williamson
The escalating threat of drug counterfeiting demands robust solutions. This article explores the pivotal role of technology, including blockchain, AI, and IoT, in anti-counterfeiting efforts. Serializ...
press releases Read more...
Thewaico Emerges from Stealth with Bioreactor Platform Built to Address Biomanufacturing's Massive Scale-Up Problem
Thewaico a bioprocess innovation company today emerged from stealth with an integrated bioreactor and bioprocess control platform developed to address one of biomanufacturings most persistent and costly failures
Seasoned Biotech Finance Executive Florian Schmid Appointed CFO of T-CURX to Support Next Phase of Growth
TCURX GmbH TCURX a biotechnology company developing nonviral CART therapies today announced the appointment of Florian Schmid as Chief Financial Officer Florian will lead the company
Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury
Pharmazz Inc Pharmazz or the Company a latestage biopharmaceutical company focused on developing and commercializing firstinclass therapeutics for critical care and neurological conditions
Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis
Genentech a member of the Roche Group SIX RO ROP OTCQX RHHBY announced today that the US Food and Drug Administration FDA has accepted the companys New Drug Application NDA under
Events Read more...
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
LATEST NEWS Read more...
Fresenius completes acquisition of mAbxience
Fresenius SE Co KGaA has completed the acquisition of the remaining stake in mAbxience from Insud Pharma giving Fresenius full ownership of the biopharmaceutical company
R1 Therapeutics expands Series A financing to $80.5 million
R Therapeutics has expanded its Series A financing to million with new investment from Samsara BioCapital The clinicalstage biopharmaceutical company will use the funding to advance AP
Immunome receives FDA clearance for IM-1340 clinical trial
Immunome has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for IM an investigational antibodydrug conjugate ADC being developed for advanced solid tumours
Novonesis Expands West Allis Facility to Strengthen North American Dairy Production
Novonesis has completed a major expansion of its production facility in West Allis Wisconsin increasing its North American capacity for dairy cultures The investment has raised fermentation capacity
4basebio and TriLink BioTechnologies Partner to Support Phase I Cell Therapy Programme
basebio has announced a partnership with TriLink BioTechnologies to support a Phase I cell therapy programme being developed by a multinational pharmaceutical company
Astoriom Acquires Additional UK Storage Business to Expand Capacity and Services
Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited the UK operations of life sciences stability storage provider Sampled based in Glasgow The acquisition expands






